Liaoning Chengda Biotechnology Co.,ltd.

Company Description

Introduction of CDBIO
Liaoning ChengDa Bio-tech Co., Ltd. (CDBIO) ; was founded in June 2002, jointly owned by Liaoning ChengDa Co., Ltd. And Liaoning Provincial Medical Equipment Institute.
The company has adopted the technology of high density microcarriers in bioreactors from BARI Consultant in USA to produce Vero Cell Rabies Vaccine for human use.
At the same time, the company has proceeded research on the Japanese Encephalitis vaccine on the basis of bioreactor technology. The sample of Japanese Encephalitis vaccine has finished the clinical trials in 2005. Liaoning Chengda Biotechnology Co.,ltd. will begin to sell Japanese Encephalitis vaccine in 2007.

Company Information

  • Contact Person:Mr. yang xu
  • Job Title:manager
  • Telephone:
  • Mobile Phone:
  • Fax:
  • Zip:110179
  • Province/State:Liaoning
  • City:Shen Yang
  • Business Type:Manufacturer
  • Year Established:2002
  • Number Of Employees:101 - 200 People
  • Total Revenue:US$50 Million - US$100 Million
  • Trade Capacity:North America : 11.11% South America : 11.11%
  • Production Capacity:- -
  • R&D Capacity:No. of R&D Staff :31 - 40 People
  • Main Products:Rabies Vaccine,Japanese Encephalitis Vaccine, Bio-technology Products,
  • Address:No. 1 Xin Fang Street. , Hunnan New District, Shenyang, China
  • Main Markets:North America, South America, Western Europe, East
  • Location:Liaoning, China (Mainland)
  • Website:Visit website

Product

  • Rabies Vaccine
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries